Pharma's Almanac TV
PA TV
Your Name
Your Email
Manage Account
Sign Out
Sign In
Register
Follow the Journey
Companies On The Road
Arcadis DPS Group
C2 Pharma
CAI
EcoLab
Environmental Systems Corporation
Federal Equipment Company
Globyz Biopharma Services
Grifols
Integrity
Nu-Tek BioSciences
PHARMALEX
Waters Corporation
Follow the Journey
Companies On The Road
ABS
aCGT Vector
Alconox Inc.
Andelyn Biosciences
Arranta Bio
Avid Bioservices
BDD
BIOVECTRA
DPS Group
Dynamk Capital
Environmental Systems Corporation
Federal Equipment Company
Genesis AEC
Globyz Biopharma Services
Grifols Partnership
IDT Biologika
Inceptor Bio
IPS-Integrated Project Services
Kineticos Life Sciences
MilliporeSigma
Montana BioScience Alliance
Olon
Rentschler Biopharma
SanaClis
Scorpion Biological Services
Secant Group
Tapemark
VITRONIC
Follow the Journey
Companies On The Road
AES Clean Technology
Altis Biosystems
Arranta Bio
Avara Pharmaceutical Services
Avid Bioservices
BioVectra
Centaur BPS
Dynamk Capital
ECRI
Evolve Biologics
Federal Equipment Company
Globyz
Inceptor Bio
IPS-Integrated Project Services
Olon
Pii
Polpharma Biologics
PPD
RoosterBio
SanaClis
Sanofi AIS
SGD Pharma
SPI Pharma
TriRx Pharmaceutical Services
Yourway
Dashboard
Topics
Products
ADC
API - Small Molecule
Biologics
Biopharmaceuticals
Biosimilars
Cell and Gene Therapy
DNA
Drug Product
Drug Substance
Equipment
Generics
Immunotherapy
Injectables
Monoclonal Antibody
Novel Therapeutics
Oral Solid Dosage
Orphan Drugs
Parenterals
Stem Cells
Vaccine
Services
Big Data
Bioprocessing
Clinical Trials
Continuous Manufacturing
Diagnostics
Drug Delivery
Drug Development
Drug Discovery
Facility
Formulation
Innovation
Oncology
Patient Adherence
Patient Centric
Preclinical
Process Development
Quality
Regulatory
Research
Serialization
Segment
Biomanufacturing
Biotechnology
CDMO
Consulting
CRO
Engineering
Equipment
Excipients
Healthcare
Intermediates
Logistics
Manufacturing
Packaging
Supply Chain
Business
Agreement
Appointment
Business
Capacity Expansion
Collaboration
Growth
Investment
Licensing
M&A
Market Expansion
Market Intelligence
Market Prediction
New Facility
Strategic Partnership
Magazine
Archive
Reports
Nice Insight Reports
2022 Sterile
2023 Cell & Gene Therapy
2023 mAb and Recombinant Protein
2024 API
2024 OSD
2024 ADC
2024 mRNA
2024 Mammalian Cell Culture
2024 Microbial Cell Culture
2024 Plasmids
2024 Gene Therapy
2024 Cell Therapy
2024 Sterile
Community
Company A to Z
Follow the Journey
Companies On The Road
Follow The Artist
Follow the Journey
Companies On The Road
More+
Staffing
Media Kit
COVID-19 (5)
253 Articles Available
5
11
Can't find what you're looking for? Try our
advanced search
.
Supply Chain Risk
The Precarious Pharmaceutical Supply Chain: To Reshore or Not to Reshore – Part 1
PAP-Q3-20-CL-020
M&A
Lessons Learned from the Ground Floor of Life Science Advising
PAP-Q3-20-NI-005
Research Insights
Approved Therapeutics for a Novel Pandemic: Drug Repurposing to Treat COVID-19
PAP-Q3-20-NI-011
Vaccine Development
The Advantages of Implementing Plant-Based Vaccines
PAP-Q3-20-CL-021
Post COVID-19 Supply Chain
Q: How are you rethinking your supply chain and operational fitness in light of the COVID-19 pandemic?
PAP-Q3-20-NI-007
COVID-19 Prevention
Preventative Nasal Spray Shown to Reduce Viral Replication by up to 96% in COVID-19 Challenge Study
PR-M09-20-31
COVID-19 Trials
Johnson & Johnson Initiates Pivotal Global Phase 3 Clinical Trial of Janssen’s COVID-19 Vaccine Candidate
PR-M09-20-27
COVID-19
Hovione Announces Partnership to Support Manufacturing of Antiviral Veklury for COVID-19
PR-M09-20-26
COVID-19
Novavax Announces COVID-19 Vaccine Manufacturing Agreement with Serum Institute of India
PR-M09-20-NI-17
Oral COVID-19 Vaccine
Vaxart Announces FDA Clearance of IND Application for Oral COVID-19 Vaccine
PR-M09-20-NI-19
COVID-19 Vaccine
Pfizer and BioNTech Announce Data from Preclinical Studies of COVID-19 Vaccine Candidate
PR-M09-20-NI-15
Diagnostic
LabCorp Launches First Combined Test for COVID-19, Flu and RSV in Time for Flu Season
PR-M09-20-NI-13
COVID-19 Vaccine Supply
CSL to Manufacture and Supply University of Queensland and Oxford University Vaccine Candidates for Australia
PR-M09-20-NI-10
COVID-19
Biopharma Leaders Unite to Stand with Science
PR-M09-20-NI-11
COVID-19 Vaccine
AMRI Selected to Support AstraZeneca in Delivery of COVID-19 Vaccine
PR-M09-20-NI-08
COVID-19
CureVac Expected to Receive up to 252 million Euros from the German Federal Ministry of Research for Further COVID-19 Vaccine Development
PR-M09-20-NI-05
Clinical Trials
Hackensack Meridian Health Enrolling Individuals for COVID-19 Vaccine Clinical Trial
PR-M08-20-NI-50
COVID-19
Gilead’s Remdesivir Receives FDA Emergency Use Authorization for the Treatment of Patients With Moderate COVID-19
PR-M08-20-NI-48
COVID-19 Vaccine
Moderna Confirms Advanced Discussions with European Commission to Supply Europe with 80 Million Doses of mRNA Vaccine Against COVID-19
PR-M08-20-NI-42
COVID-19 Vaccine
Catalent Signs Agreement with AstraZeneca to Expand Manufacturing Support for COVID-19 Vaccine AZD1222
PR-M08-20-NI-41
COVID-19 Treatment
TFF Pharmaceuticals Enters into Worldwide Licensing Agreement with UNION Therapeutics for COVID-19 Treatment
PR-M08-20-NI-40
COVID-19
QIAGEN to Launch Digital SARS-CoV-2 Antibody Test
PR-M08-20-NI-37
COVID-19 Treatment
AeroNabs Promise Powerful, Inhalable Protection Against COVID-19 Inspired by Llamas
PR-M08-20-NI-29
Diagnostic Testing
FDA Issues Emergency Use Authorization to Yale School of Public Health for SalivaDirect COVID-19 Test
PR-M08-20-NI-27
«
5
11
»
.svg)